<DOC>
	<DOCNO>NCT01931475</DOCNO>
	<brief_summary>The purpose study assess efficacy safety duloxetine daily compare placebo reduction pain due osteoarthritis ( OA ) knee hip participant China .</brief_summary>
	<brief_title>A Study Duloxetine Participants With Chronic Pain Due Osteoarthritis China</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Meet clinical radiographic criterion diagnosis OA knee hip pain ≥14 day month 3 month prior study entry Have rating ≥4 Brief Pain Inventory ( BPI ) 24hour average pain item ( Question 3 BPI modify short form ) Screening Randomization Have previously completed/withdrawn study study investigate duloxetine ( Note : Participants previously screen duloxetine study study never receive investigational product eligible study meet current entry criterion ) Have previous exposure duloxetine Have previous diagnosis psychosis , bipolar disorder , schizoaffective disorder Current ( within 1 year Screening ) Diagnostic Statistical Manual Mental Disorders , Fourth Edition Axis I diagnosis major depressive disorder , anxiety disorder ( exclude phobia ) , alcohol eat disorder , determine MiniInternational Neuropsychiatric Interview previous diagnosis Have history substance abuse dependence within past year , exclude nicotine caffeine Are take excluded medication discontinue Screening Have treatment monoamine oxidase inhibitor ( MAOI ) within 14 day randomization potential need use MAOI study within 5 day discontinuation investigational product Have positive urine drug screen substance abuse exclude medication Have serious cardiovascular , hepatic , renal , respiratory , hematologic illness , medical psychiatric condition , opinion investigator , would compromise participation likely lead hospitalization course study Have history recurrent seizure febrile seizure Are judge clinically investigator suicidal risk accord Columbia Suicide Severity Rating Scale ( CSSRS ) : `` Yes '' answer either Question 4 ( Active Suicidal Ideation Some Intent Act , Without Specific Plan ) Question 5 ( Active Suicidal Ideation Specific Plan Intent ) '' Suicidal Ideation '' portion CSSRS `` Yes '' answer suicide relate behavior ( actual attempt , interrupt attempt , abort attempt , preparatory act behavior ) `` Suicidal Behavior '' portion CSSRS , ideation/behavior occur within previous month Have uncontrolled narrowangle glaucoma Have acute liver injury ( hepatitis ) severe cirrhosis Have know hypersensitivity duloxetine inactive ingredient frequent/severe allergic reaction multiple medication Have frequent fall could result hospitalization could compromise response treatment Have diagnosis inflammatory arthritis [ , rheumatoid arthritis ( RA ) ] autoimmune disorder ( exclude inactive Hashimoto 's thyroiditis ) Have receive intraarticular hyaluronate/steroids , joint lavage , invasive therapy index joint previous 3 month Have arthroscopy index joint within previous year joint replacement index joint time Have surgery index joint schedule occur trial anticipate investigator require surgery treatment OA index hip knee along duration study Have prior synovial fluid analysis show white blood cell ( WBC ) count ≥2000 cubic millimeter ( mm3 ) indicative diagnosis OA Are nonambulatory require use crutch walker Have body mass index &gt; 40 Are anticipated investigator require use analgesic agent include , limited , nonsteroidal antiinflammatory drug ( NSAIDs ) , acetaminophen/paracetamol , opioids , exclude medication duration study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>